TY - THES A1 - Seupel, Raina T1 - Antiinfektive und Antitumorale Naphthylisochinolin-Alkaloide: Isolierung und Strukturaufklärung, Totalsynthese und Untersuchungen zum Wirkmechanismus T1 - Antiinfective and Antiturmoral Naphthylisoquinoline Alkaloids: Isolation and Elucidation, Total Synthesis, and Investigations on the Mode of Action N2 - Bedingt durch ihre strukturelle Diversität und biologischen Eigenschaften sind Naturstoffe seit jeher Quelle und Inspiration für Arzneimittel vor allem im therapeutischen Bereich der Onkologie und der Infektionskrankheiten. Ihr einzigartiges pharmakologisches Potenzial wird durch die selektive Interaktion mit einer Vielzahl von Zielmolekülen hervorgerufen. Aufgrund der zentralen Bedeutung von Naturstoffen in der Entdeckung und Entwicklung von neuen Arzneimitteln sind nach wie vor die Isolierung und Strukturaufklärung, die totalsynthetische Darstellung und Derivatisierung sowie die Identifizierung der Zielmoleküle und die Aufklärung des Wirkmechanismus dieser natürlichen Wirkstoffe unabdingbar. Die kleine, aber spannende Klasse der Naphthylisochinolin-Alkaloide, die ausschließlich aus den beiden Pflanzenfamilien der Dioncophyllaceae und der Ancistrocladaceae gewonnen werden, zeichnet sich mit ihren mehr als 200 Vertretern nicht nur durch ihre strukturelle Vielfalt aus, sondern zeigt vor allem pharmakologisch interessante Wirksamkeiten. Neben ausgeprägten In-vitro-Aktivitäten gegen protozoische Erreger wie Leishmanien, Plasmodien und Trypanosomen besitzen die Vertreter dieser einzigartigen Naturstoffklasse nach neuesten Untersuchungen auch vielversprechende antitumorale Aktivitäten. Für deren Weiterentwicklung zu möglichen Arzneistoffen ist es daher unabdingbar, ihr pharmakologisches Potenzial tiefergehend zu untersuchen. Ziel der vorliegenden Dissertation war die Entwicklung totalsynthetischer Zugänge zu biologisch interessanten Naphthylisochinolin-Alkaloiden mit Hilfe unterschiedlicher Synthesestrategien. Ebenfalls sollten durch die Darstellung strukturell vereinfachter Derivate sowie markierter Naturstoffe in Zusammenarbeit mit Kooperationspartnern mögliche Zielmoleküle identifiziert und Beiträge zum Wirkmechanismus untersucht werden. N2 - Due to their structurally diversity and biological properties, natural products have been, for a long time, a source and inspiration for drugs, especially in the therapeutic areas of oncology and infectious diseases. Their unique pharmacological potential is a result of their selective interaction with a variety of target molecules. Owing to the central role of natural products in the discovery and development of new drugs, the isolation, structural elucidation, the total synthesis and derivatization, the identification of target molecules, and investigations on the mode of action of these natural compounds are still essential. The small, yet fascinating class of naphthylisoquinoline alkaloids, which are exclusively obtained from the two plant families of Dioncophyllaceae and Ancistrocladaceae, does not only stand out due to their structural diversity with more than 200 representatives, but also shows pharmacologically interesting activities. In addition to pronounced in vitro activities against protozoan pathogens such as leishmania, plasmodia and trypanosoma, the representatives of this unique class of natural products also show promising antitumoral activities. For their further development as possible drugs, their pharmacological potential has to be investigated in more detail. The aim of the present thesis was the development of total synthetic approaches to biologically interesting naphthylisoquinoline alkaloids by means of different strategies. The synthesis of structurally simplified derivatives and of labeled natural products together with cooperation partners was also intended to identify potential targets and contribute to the mode of action. KW - Naphthylisochinolinalkaloide KW - Organische Synthese KW - Naturstoffe KW - Natural products KW - Totalsynthese KW - Isolierung KW - Strukturaufklärung KW - Wirkmechanismus KW - total synthesis KW - isolation KW - structure elucidation KW - mode of action Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-167950 ER - TY - JOUR A1 - Brünnert, Daniela A1 - Seupel, Raina A1 - Goyal, Pankaj A1 - Bach, Matthias A1 - Schraud, Heike A1 - Kirner, Stefanie A1 - Köster, Eva A1 - Feineis, Doris A1 - Bargou, Ralf C. A1 - Schlosser, Andreas A1 - Bringmann, Gerhard A1 - Chatterjee, Manik T1 - Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate JF - Pharmaceuticals N2 - The N,C-coupled naphthylisoquinoline alkaloid ancistrocladinium A belongs to a novel class of natural products with potent antiprotozoal activity. Its effects on tumor cells, however, have not yet been explored. We demonstrate the antitumor activity of ancistrocladinium A in multiple myeloma (MM), a yet incurable blood cancer that represents a model disease for adaptation to proteotoxic stress. Viability assays showed a potent apoptosis-inducing effect of ancistrocladinium A in MM cell lines, including those with proteasome inhibitor (PI) resistance, and in primary MM cells, but not in non-malignant blood cells. Concomitant treatment with the PI carfilzomib or the histone deacetylase inhibitor panobinostat strongly enhanced the ancistrocladinium A-induced apoptosis. Mass spectrometry with biotinylated ancistrocladinium A revealed significant enrichment of RNA-splicing-associated proteins. Affected RNA-splicing-associated pathways included genes involved in proteotoxic stress response, such as PSMB5-associated genes and the heat shock proteins HSP90 and HSP70. Furthermore, we found strong induction of ATF4 and the ATM/H2AX pathway, both of which are critically involved in the integrated cellular response following proteotoxic and oxidative stress. Taken together, our data indicate that ancistrocladinium A targets cellular stress regulation in MM and improves the therapeutic response to PIs or overcomes PI resistance, and thus may represent a promising potential therapeutic agent. KW - multiple myeloma KW - ancistrocladinium A KW - naphthylisoquinoline alkaloids KW - proteasome inhibitor resistance KW - RNA splicing KW - cellular stress response KW - proteasome subunit beta type-5 (PSMB5) KW - activating transcription factor 4 (ATF4) KW - ataxia teleagiectasia mutated (ATM) KW - H2A histone family member X (H2AX) Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-362887 SN - 1424-8247 VL - 16 IS - 8 ER -